Stockreport

Spruce Bio jumps after breakthrough therapy status for enzyme replacement therapy [Seeking Alpha]

Spruce Biosciences, Inc.  (SPRB) 
PDF FDA has awarded breakthrough therapy designation to its treatment, tralesinidase alfa enzyme replacement therapy (TA-ERT), for sanfilippo syndrome type B. The stock ex [Read more]